Research and Markets Unique insight to 1350 deals and alliances that took place for Cardiovascular Diseases during 2000 to 2005
Deals and Alliances Therapy Report - Cardiovascular Diseases provides an in-depth view of over 1350 deals and alliances announced in cardiovascular diseases between 2000 and 2005, in a clear and accessible PDF format.
The report contains:
- fully categorized deal overviews
- financial information where disclosed
- company profiles of the top 25 dealmakers in the report
- specialized indexes including deal type, therapy area, industry sector and stage of development
- an alphabetical index of company activity.
The report helps in:
- identifying active partners
- tracking competitor activity
- benchmarking deals
- comparing the finances of different deal types.
Deals and Alliances Therapy Report - Cardiovascular Diseases brings all the relevant partnering deals into one place, providing a ready reference to deal making in cardiovascular diseases .
This report is essential reading for board and executive management, and individuals in:
- business development
- licensing/partnering
- deal making
- business strategy
- marketing and promotion
- distribution and manufacturing (including contract services).
Contents include:-
Introduction
A summary of the deals and dealmakers over a five-year period. Includes charts and tables summarizing activity in the therapy area.
Chapter 1: Deals by company
A comprehensive overview listing deals by company, with a full index of all the deals announced. A clear and easy way to see the activities of any company.
Chapter 2: Deals by development stage
A review of deals by stage of development. Appreciate how deal values change from discovery to launch in the therapy area.
Chapter 3: Summary profiles for the most active companies
Summary profiles for the most active companies in the therapy area over the past five years, including history, business strategy, partnering strategy, and deals listing.
Chapter 4: List of deals
A full index of all the deals announced between May 2000 and April 2005. Entries contain financial information such as headline value, upfront and royalty rates, where available.
Every deal is fully categorized, includes a detailed description, and includes financials such as headline value, upfront payments and royalty rates, where disclosed, and links to the full deal in the deal listing at the rear of each report.
List of Charts
Fig. 1 Deal activity 2000-2005
Fig. 2 Deal activity last 12 months
Fig. 3 Deal activity in cardiovascular diseases by year
Fig. 4 Deal activity in cardiovascular diseases by type
Fig. 5 Deal activity in cardiovascular diseases by development stage
For more information visit http://www.researchandmarkets.com/reports/c20149
Laura Wood
Senior Manager
Research and Markets
Fax: +353 1 4100 980
Research and Markets Unique insight to 1350 deals and alliances that took place for Cardiovascular Diseases during 2000 to 2005
2912 readers online...
- Syndication Directory
- Cardiology
- Comedian Dana Carvey To
- Gmeds Gcare„ Version 4.0
- Tim Russerts Untimely De
- University of Miamis Mil
- Cardiocore Adds European
- Heart Attack Is Not an E
- SHAPE Applauds Dallas He
- How To Make the Best Inf
- Did A Family Member Die
- BioCardia Completes $7.4
- Lifeclinic International
- Empower Your Spiritual E
- NourishLife In Honor of
- Americas Watchdog Wants
- Gamma Scintillation Came
- BioCardia and the Univer
- Holter Monitoring System
- Cardiovascular Catheters
- Ovalum Ltd. releases for
- Worldwide Sales of DrugE
- Cleveland Clinic Release
- pMDsoft Releases Charge
- Dr. Asa Andrew Focuses o
- Aerotel Medical Systems
- Medicare Increases Reimb
- AlsoSalt the First Palat
- InternationallyRenowned
- Research and Markets Hea
- Reversing Heart Disease
- First Human FetalDerived
- First Human FetalDerived
- BioCardia Inc Releases t
- Good Samaritan Hospital
- Heart Birth Defect Aware
- New Vioxx Search Engine
- World Financial News Net
- Millions of Americans th
- NIH National Study Testi
- FibrinogenMajor KillerHi
- ATOPJOBcom Nurse Practit
- Baxa Introduces Four New
- The Most Important Healt
- Inflammation Heart Atta
- Biosignetics Believes it
- Homocysteine Levels Acce
- Pharmacy Errors Need Rep
- Summa Design Announces C
- The Role of HighDensity
- SCIREX Expands European
- Outsourcing Major Surgery